The front page of AI-driven biology
Thursday, October 15, 2026Thu, Oct 15
Updated 5:32 PM PT
Former Genentech artificial intelligence leaders, including New York University professor Kyunghyun Cho, have launched the health startup Ortet backed by a $500 million commitment from Matt Holt's investment firm Thoreau.
UPMC Enterprises and Ziff Capital Partners co-led the $48 million launch round for ai3Bio, formed by combining autoimmune assets from Corner Therapeutics with University of Pittsburgh spinout Novasenta.
Goa Therapeutics launched with $15.5 million in funding from individual industry leaders and filed for an initial public offering to raise up to $75 million.
Chinese internet company ByteDance completed a $290 million funding round for its AI-driven drug discovery division following its spin-out as an independent company.
The Mayo Clinic and Thermo Fisher Scientific have launched Precure LLC, a joint venture built to assemble large-scale datasets combining genomic, proteomic, and longitudinal clinical records.